Upstream Technology

Boehringer Ingelheim BioXcellence's™ broad expertise in upstream processing enables fast-track development of high-quality, high-titer processes for the production of biopharmaceuticals from mammalian cell cultures and microbial and yeast fermentations.

We have extensive experience with a variety of different host cell and strain types, including CHO, NS0, SP2.0, E. coli, Pichia Pastoris, Saccharomyces cerevisiae and Pseudomonas fluorescens; as well as different molecule types such as monoclonal antibodies, recombinant glycosylated and non-glycosylated proteins, antibody fragments, Fc-Fusion proteins, protein scaffolds and plasmid DNA.

For our contract manufacturing customers, all high expression systems are royalty free.


Contact Us

Boehringer Ingelheim BioXcellence - Contact Us

Do you have any inquiries, questions or comments? Please get in touch with us.